Skip to Content

GS UHL (Votrient pazopanib 400 mg)

Generic Name: pazopanib

Pill with imprint GS UHL is Yellow, Capsule-shape and has been identified as Votrient pazopanib 400 mg. It is supplied by GlaxoSmithKline.

Votrient is used in the treatment of soft tissue sarcoma; renal cell carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS UHL

Votrient

Generic Name
pazopanib
Imprint
GS UHL
Strength
pazopanib 400 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Vegf/vegfr inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.